NCT00840216View on ClinicalTrials.gov

Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions.

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

August 31, 2002

Study Completion Date

August 31, 2002

Conditions
Healthy
Interventions
DRUG

Clarithromycin ER 500 mg tablets

1 x 500 mg

DRUG

BIAXIN® XL 500 mg tablets

1 x 500 mg

Trial Locations (1)

63301

Gateway Medical Research Inc., Saint Charles

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00840216 - Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions. | Biotech Hunter | Biotech Hunter